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Peripheral quantitative computed tomography (pQCT) is a useful tool to assess detailed bone 
characteristics. Its utility in infants is however limited due to lack of reference data and technical 
challenges. The purpose of this study was to provide data on length- and weight-adjusted pQCT 
values and to present a quality grading system for healthy children aged 12 and 24 months.  
Material and methods 
As a part of the Vitamin D intervention in Infants (VIDI) trial, we collected pQCT and 
anthropometric data from 855 children at 12 months and from 784 children at 24 months. Bone 
mineral content (BMC; mg/mm), volumetric bone mineral density (vBMD; mg/cm3), cross-
sectional area (CSA; mm2), polar-moment of inertia (PMI; mm4), and periosteal circumference 
(PsC; mm) were assessed for total bone at 20% distal site of the left tibia using pQCT (Stratec 
XCT2000L). We evaluated the impact of scan quality on bone measures. Total bone parameters 
were assessed for boys and girls separately. The means of the bone parameters were also compared 
in relation to age. The associations between bone parameters and weight, length, sex and scan 
quality were analyzed.  
Results 
We included scans with sufficient quality (Grade 1-5) in the final analyses: 679/855 (79%) at 12 
months and 709/784 (90%) at 24 months. Altogether 39% of the scans at 12 months and 51% at 24 
months were of good or excellent quality (Grade 1-2). Scan quality had an impact on BMCs at 12 
and 24 months (p=0.001 and p=0.017, respectively) but not on other bone parameters. Boys 
presented greater total bone BMC, CSA, PMI and PsC values at 12 and 24 months but vBMDs were 
similar. All bone parameters showed a significant increase between 12 and 24 months for both 
sexes. When adjusting bone parameters for weight, length and scan quality, differences between 
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sexes disappeared. Weight was the strongest modifier of BMC, CSA, PMI and PsS at 12 and 24 
months.  
Conclusions 
This study increases our understanding on bone parameters in young children and demonstrates the 
suitability of pQCT in bone research in infants. The described pQCT data and scan quality grading 





Interest towards childhood bone health has grown in recent years. Bone mineral accrual during 
childhood affects skeletal health in adulthood, and high peak bone mass attained during early life 
may be protective against osteoporosis and fractures at older age [1-3]. Chronic diseases and 
pharmaceutical agents in childhood may have a negative effect on bone strength and contribute to 
increased fracture risk [4-7]. In order to evaluate the impact of various factors that may affect bone 
health, adequate tools are needed to distinguish between normal and impaired bone strength. 
Several different bone densitometry methods can be applied in children [8]. Dual-energy X-ray 
absorptiometry (DXA) remains the most common in clinical practice for its wide availability, 
precision, low radiation exposure and for being relatively easy and inexpensive to use [9]. The 
current recommendations, updated by the International Society for Clinical Densitometry Official 
Positions in 2013, support the use of DXA for clinical densitometry in infants and young children 
[10, 11]. However, especially for children younger than 3 years, normative data for any 
measurement technique are scarce. DXA-derived lumbar spine BMD is the only assessment method 
for which sufficient reference data in this age group exist [10]. 
Peripheral quantitative computed tomography (pQCT) has been successfully used in neonates, 
infants and small children [12-15], as well as in preschool- and school-aged children [16]. The 
advantage of pQCT compared with DXA is that it allows three-dimensional examination of bone 
geometry as well as separation between different cortical and trabecular bone compartments and 
muscle. It also allows volumetric bone mineral density and other bone measures to be examined 
without being influenced by the size of the child. While DXA provides data mostly for central bone 
parameters and body composition, pQCT allows examination of bone parameters at peripheral sites. 
pQCT is also relatively inexpensive and involves low radiation exposure (<1µSv per scan). Some 
pQCT reference data exist for children older than 5 years of age [17, 18] but, to the best of our 
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knowledge, no such large pQCT data have been reported for younger children and especially for 
infants. 
We carried out a large prospective vitamin D intervention study (VIDI) among 975 healthy term-
born infants during 2013-2016 [19]. As a part of the trial, we collected data on tibial total bone 
measures at 12 and 24 months of age using pQCT as a densitometric method. Here, we describe the 
practical approach how to conduct pQCT assessments in young children, present a grading system 
to evaluate the impact of scan quality on measurements, demonstrate how weight, length, scan 
quality and sex affect bone parameters, and provide length- and weight-adjusted tibial pQCT data 
for 12 and 24 months old healthy girls and boys. 
2. Materials and Methods 
2.1 Participants 
The study cohort consisted of 975 children who were included in our randomized, double-blind 
Vitamin D Intervention in Infants (VIDI) trial between January 2013 and June 2016. The VIDI 
study compared the effects of vitamin D3 supplementation on bone strength and infections during 
the first 24 months of life in children who received either 10 µg (Group10) or 30 µg (Group30) 
daily supplemental dose from age 2 weeks to 24 months [19]. All children were born full-term and 
with normal weight and were of Northern European ethnicity. Study protocol, inclusion and 
exclusion criteria and primary outcome measures have previously been described in more detail [19, 
20].  
Participants attended follow-up visits at 12 and 24 months of age. Length (cm) and weight (kg) 
were measured and corresponding standard deviation scores (SDS) determined using Finnish 
pediatric growth references [21]. Length adjusted weight percentage was calculated and 
standardized into sex-specific standard deviation score (SDS). Blood 25-hydroxyvitamin D 
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concentrations were analyzed at birth (umbilical cord blood), and at 12 and 24 months of age, as 
previously reported [19]. 
The VIDI study protocol was approved by the Research Ethics Committee of the Hospital District 
of Helsinki and Uusimaa (ID 107/13/03/03/2012) and was registered in ClinicalTrials.com 
(NCT01723852). All families who agreed to participate gave a written informed consent after 
having received information about the study.  
2.2 pQCT data collection 
Bone outcomes were measured using pQCT technique (XCT2000L Research+, Stratec 
Medizintechnik GmbH, Pforzheim, Germany) at 12 and 24 months of age. Because dominant leg 
cannot be determined in this age group, we used the left tibia for all participants. The length of tibia 
was measured from the medial malleolus to the medial condyle, and the scanning site at 20% distal 
length was marked with a color line. We measured a single slice with a 2.0 mm thickness, 0.40 mm 
voxel size and 25 mm/s scan speed. We used a leg stabilizer to fix the position of the leg during 
measurement, and the leg was also supported by the researcher (Fig. 1).  
All children were measured in a sitting position on the parent’s lap. The region of interest (ROI) 
around tibia was manually set for each scan. All pQCT measurements were performed by 
experienced and trained research personnel. 
2.3 pQCT quality assessment and analysis 
Since no scan quality grading for this age group has previously been reported, we developed our 
own grading protocol, based on an earlier study in pubertal children [22]. We agreed on the grading 
criteria prior to scan analysis and in uncertain cases, reviewed the scans together for consensus. 
Grading criteria were based on the amount of movement artefacts and whether the cortex of the 
tibia was intact or not. If the bone shape could not be recognized or the scanning site was incorrect, 
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the scan was defined as failed. All scans were individually reviewed and graded from Grade 1 to 6 
as follows: 1=excellent, 2=good, 3=moderate, 4=sufficient, 5=poor, 6=failed (Fig. 2). Grade 6 
measurements were omitted from further analyses. 
We used the loop function of the manufacturer’s software version 6.20 C to analyze the Grade 1-5 
scans. A threshold of 180 mg/cm3 with peeling mode 1 was used to filter out soft tissue in order to 
determine total bone, and a threshold of 400 mg/cm3 to define the cortical compartment. These 
thresholds were based on a previous study in infants [13]. The precision of the thresholds was 
pretested with a smaller subset of 100 scans before running the final analyses. 
We determinated bone mineral content (BMC; mg/mm), volumetric bone mineral density (vBMD; 
mg/cm3), cross-sectional area of the bone (CSA; mm2), polar moment of inertia (PMI; mm
4) and 
periosteal circumference (PsC; mm) for total bone at 20% distal length of the left tibia. We found 
that in our cohort 99% of the scans at 12 months and 89% at 24 months had a mean cortical 
thickness less than 2 mm. As previous studies have shown, there are significant problems 
measuring cortical bone outcomes if cortical thickness is less than 2 mm [23]. Therefore we decided 
to exclude cortical bone results from our analysis. 
2.4 Statistical analysis 
Results are presented as means and 95% confidence intervals (95% CI) or medians and 25% and 
75% IQRs. The normality of the variables was assessed using visual inspection and Kolmogorov-
Smirnov test. Logarithmic transformation was used for non-normally distributed variables where 
appropriate. We used an independent samples T-test in unadjusted analyses when comparing 
anthropometric, biochemical and bone characteristics between two groups. Analysis of covariance 
(ANCOVA) was used for adjusted analyses between sexes. Comparisons between groups of three 
or more were performed using analysis of variance (ANOVA) for normally distributed variables or 
Kruskall-Wallis test for variables lacking equal variance. Tukey test was used as a post hoc test, 
9 
 
with Bonferroni correction for multiple comparison. Pearson Chi-Square was used for comparison 
of categorical variables. Pearson correlation was used to explore the association between bone 
parameters and other variables. Covariates for linear regression were chosen based on these 
correlations. A multiple regression analysis was assessed to observe linear associations between 
bone parameters and independent variables. In linear regression, residuals were plotted to assess 
their normal distribution and evaluate homoscedasticity. 
Statistical significance for all tests was set at p <0.05. Statistical analyses were performed using 
IBM SPSS version 24 (IBM) for Windows.  
3. Results 
3.1 Cohort characteristics 
A total of 975 participants (50% girls) were included in the study. Of them, 865/975 (89%) children 
attended a follow-up visit at 12 months and 823/975 (84%) at 24 months. Cohort characteristics are 
presented in Table 1.  
Length (cm) and weight (kg) were greater in boys than in girls at birth and during entire follow-up 
(p<0.001). Length SDS at birth and length-adjusted-weight SDS at 12 months were also greater in 
boys than girls (p=0.039 and p=0.012, respectively). 
Majority of the children were vitamin D sufficient (25-OHD > 50 nmol/L) throughout the study: 
96% at birth, 99% at 12 months, and 99% at 24 months. As previously reported [19], the vitamin D 
intervention did not have an impact on the pQCT outcomes at 12 or 24 months. Therefore we 
pooled the data from both intervention groups in further analyses. 
3.2 pQCT grading 
Altogether 855/865 (99%) children were scanned with pQCT at 12 months and 784/823 (95%) at 24 
months (Fig. 3).  
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We included Grade 1-5 scans in the final analyses: 679/855 (79%) at 12 months and 709/784 (90%) 
at 24 months. The number of excellent or good quality scans (Grade 1-2) was 264/679 (39%) at 12 
months and 360/709 (51%) at 24 months. Distribution into different Grade groups did not differ 
between girls and boys at 12 or 24 months (p=0.382 and p=0.281, respectively). When comparing 
the means of bone parameters according to grading, no difference was observed between each 
Grade (1 to 5) (ANOVA p >0.1 for all) or between good-quality (Grade 1-2) and all (Grade 1-5) 
scans.  
3.3 Sex-specific total bone pQCT outcomes 
Table 2 illustrates the sex-specific total bone results at 12 and 24 months. In unadjusted analyses, 
boys had significantly greater BMC, CSA, PMI and PsC values (p<0.01 for all) than girls at 12 and 
24 months, whereas no difference between the sexes was observed for vBMD. After adjusting data 
for length (cm), weight (kg) and Grade, all differences between sexes disappeared. 
Sex-specific pQCT data for total BMC, vBMD, CSA, PMI and PsC for children at 12 and 24 
months are presented in Suppl. fig. 1. As seen in these figures, all values increased both in girls and 
boys from 12 to 24 months, the changes being of similar magnitude in both sexes. 
3.4 Associations of weight, length, sex and scan quality with total bone pQCT parameters 
We examined the associations between total bone parameters and independent variables (weight, 
length, sex and Grade) with a multiple linear regression (Tables 3 and 4). Weight associated with all 
bone parameters except vBMD at 12 and 24 months (p<0.001 for all) and was the strongest 
modifier of BMC, CSA, PMI and PsC. Length was significantly associated with BMC, CSA, PMI 
and PsC at 24 months (p<0.005 for all) but not at 12 months whereas Grade was significantly 
associated with BMC at 12 and 24 months (p=0.001 and 0.017, respectively). Sex was not a 




When all scans taken at 12 and 24 months were pooled and divided into five subgroups according to 
weight, all bone parameters differed among the subgroups (Fig. 4, Suppl. table 1). Similar 
differences were seen when the scans were compared in subgroups according to length (Fig. 5, 
Suppl. table 2). Suppl. fig. 2 illustrates the distribution of Grade 1-2 and Grade 3-5 scans for BMC 
and vBMD according to weight and length and sex.  
 
Discussion 
As part of the Vitamin D Intervention in Infants (VIDI) trial, we here report detailed pQCT data on 
tibial total bone measurements in 679 children at 12 months and in 709 children at 24 months of 
age. All children were born at term, healthy and with normal birth measurements. In addition, we 
present a grading protocol and a practical approach to be considered when implementing pQCT 
measurements in bone health studies involving infants and toddlers. To our knowledge, this is the 
largest study to report bone parameters measured with pQCT in small children. 
Despite the fact that the pQCT method has served as a useful tool for bone assessments in the 
research field since the early 1970s [24], pQCT studies among pediatric populations are rather 
limited. Some studies have established pQCT reference data on radius or tibia in older children and 
adolescents [16-18, 25], but no reference data for smaller children and especially infants exist. This 
was also noted in the 2013 ISCD Pediatric Official Positions guidelines on bone densitometry 
where the lack of pQCT reference data for infants and young children was highlighted [10]. 
Measurement techniques differ greatly between the studies [25] and there is no consensus on how 
measurements should be assessed, which scan locations to use, or which variables to report. One 
European study reported age- and height-related reference data for tibial trabecular and cortical 
vBMD, BMC, and CSA in healthy 5-19-year-old participants using 4%, 14% and 38% distal tibial 
length of the dominant leg as scanning sites [26]. Another pQCT study established height-specific 
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normal ranges and sex-specific centile curves for trabecular BMD, total and cortical CSA, cortical 
BMC, BMD, and cortical thickness in 416 subjects aged 5 to 18 years, using the 4% and 66% tibial 
sites of non-dominant tibia [27]. A third study reported reference curves for cortical BMD in 
relation to age and race in 665 children and adults from 5 to 35 years of age, using a scanning site at 
38% of left tibia [28]. Our aim was to measure tubular bone that is not too close to the growth plate, 
in order to avoid potential sources of positioning and measurement error. Therefore, we chose to 
use the 20% distal length of the left tibia as a measurement site. This was in line with the study by 
Binkley et al. which reported reference centile curves for 231 subjects between 5 and 22 years using 
a single pQCT slice at 20 % distal tibial length [18].  
Studies on sex-related differences in bone parameters are limited in this age group. One previous 
study using DXA measurements in infants and toddlers aged 1-36 months showed boys to have 
greater lumbar spine BMC than girls without any difference in areal BMD [29]. In our analyses, 
boys presented greater total bone BMC, CSA, PMI and PsC than girls but no sex-related difference 
was seen in vBMD. However, when we adjusted the bone variables for length, weight and quality 
grading, differences between sexes disappeared. In a multiple regression analysis, bone results were 
strongly influenced by body size and sex was not as significant predictor for bone parameters as 
were weight or length. This should be noted when interpreting pQCT data in infants. In line with 
this, we present the data for various bone parameters by weight and length and not by age or sex. 
Obtaining pQCT scans in this age group is technically challenging in order to avoid movement 
during scanning: we excluded altogether 21% of the scans at 12 months and 10% at 24 months due 
to movement artifacts. However, in contrast to the pQCT study by Blew et al. that showed a 
correlation between greater amount of movement artifacts and total bone CSA [22], grading only 
impacted BMC in our study. We performed a single scan and did not use a scout view (a 2D coronal 
projection used to position scans) in order to keep the scanning and radiation exposure as low as 
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possible. It is possible that repeated measurements or the use of a scout view could have improved 
the precision of the measurements [22, 30]. Despite these limitations we regard our unique data as 
valuable and the provided data important for improving and expanding bone health research in early 
childhood.  
In conclusion, we performed pQCT measurements at the 20% distal tibial site in 855 children at 12 
months and in 784 children at 24 months of age and included 679 (79%) of the scans taken at 12 
months and 709 (90%) scans taken at 24 months in the final analyses. We examined a large number 
of healthy children with good adherence to the study protocol, permitting assessment in the same 
child at 12 and 24 months. Newborns with a growth restriction were excluded and the vast majority 
of the participants were vitamin D sufficient. Our study demonstrates that pQCT is a feasible tool 
when evaluating bone health in infants and toddlers. We provide length- and weight-specific pQCT 
values for 12  and 24 months old children and present a novel grading system for scan quality 
assessment. We describe how anthropometric factors, scan quality or sex associate with bone 
parameters. However, future studies are needed to evaluate how other factors, such as dietary 
patterns or age at walking, influence pQCT outcomes, and to see how the presented data can be 
utilized in various bone health and intervention studies in this age group. 
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TABLE 1. Anthropometric and biochemical characteristics as mean (95% CI)  
at birth and during follow-up according to sex. 
ANTHROPOMETRIC CHARACTERISTICS 
BIRTH Boys (N=490) Girls (N=485) p 
Length (cm) 50.7 (50.5; 50.8) 50.0 (49.9; 50.2) <0.001 
Length SDS -0.3 (-0.3; -0.2) -0.1 (-0.2; -0.1) 0.039 
Weight (kg) 3.6 (3.5; 3.6) 3.5 (3.5; 3.5) <0.001 
Length adjusted weight SDS 0.1 (0.0; 0.2) 0.1 (0.0; 0.2) 0.851 
12 MONTHS Boys (N=427) Girls (N=438) p 
Length (cm) 76.5 (76.2; 76.7) 74.5 (74.3; 74.8) <0.001 
Length SDS -0.5 (-0.6; -0.4) -0.6 (-0.7; -0.5) 0.051 
Weight (kg) 10.2 (10.1; 10.3) 9.4 (9.3; 9.5) <0.001 
Length adjusted weight SDS 0.1 (0.0; 0.2) -0.1 (-0.2; -0.0) 0.012 
Tibial length 137.6 (136.4; 138.8) 136.0 (134.8; 137.2) 0.068 
24 MONTHS Boys (N=408) Girls (N=414) p 
Length (cm) 88.7 (88.4; 89.0) 87.0 (86.7; 87.3) <0.001 
Length SDS -0.2 (-0.3; -0.1) -0.3 (-0.4; -0.2) 0.350 
Weight (kg) 13.0 (12.8; 13.1) 12.2 (12.0; 12.3) <0.001 
Length adjusted weight SDS 0.0 (-0.1; 0.1) -0.1 (-0.2; 0.0) 0.116 
Tibial length 168.3 (167.4; 169.2) 165.9 (165.1; 166.8) <0.001 
BIOCHEMICAL CHARACTERISTICS 
25-OHD (nmol/L) Boys Girls p 
Birtha 83.1 (80.8; 85.4) 79.9 (77.6; 82.3) 0.059 
12 monthsb 98.1 (95.2; 101.0) 99.7 (96,9; 102.5) 0.434 
24 monthsc 101.1 (98.4; 103.9) 103.4 (100.7; 106.1) 0.255 
Number of participants are given if less than 95% from total n: a n=483/472, b n=393/411, c n=402/412 




TABLE 2. Sex-specific bone characteristics at 12 and 24 months as mean and 95% CI 
 Unadjusted model Adjusted model^ 
 Boys Girls pa Boys Girls pb 
12 MONTHS 
N (%) 328 (48) 351 (52) N/A 328 (48) 350 (52) N/A 
BMC (mg/mm) 37.0 (36.2; 37.9) 33.9 (33.0; 34.7) <0.00
1 
35.9 (35.1; 36.8) 34.9 (34.1; 35.7) 0.078 
vBMD (mg/cm3) 301.2 (293.3; 309.2) 293.6 (285.8; 301.3) 0. 75 299.7 (291.4; 308.0) 295.0 (287.0; 303.1) 0.449 
CSA (mm
2) 127.2 (123.6; 130.8) 120.6 (117.1; 124.1) 0.009 124.2 (120.5; 127.8) 123.5 (119.9; 127.0) 0.793 
PMI (mm4) 2822.2 (2651.8; 2992.6) 2550.5 (2385.8; 2715.3) 0.002
^^ 
2691.9 (2518.0; 2865.8) 2672.3 (2504.6; 
2840.0) 
0.651^^ 
PsC (mm) 39.7 (39.1; 40.2) 38.6 (38.1; 39.1) 0.005 39.2 (38.6; 39.7) 39.0 (38.0; 39.6) 0.723 
24 MONTHS 
N (%) 335 (47) 374 (53) N/A 335 (47) 374 (53) N/A 
BMC (mg/mm) 56.1 (55.3; 56.9) 52.9 (52.1; 53.7) <0.00
1 
54.8 (54.0; 55.5) 54.1 (53.4; 54.8) 0.212 
vBMD (mg/cm3) 381.6 (373.4; 389.8) 374.6 (366.8; 382.3) 0.221 380.2 (371.8; 388.5) 375.8 (367.9; 383.7) 0.472 
CSA (mm
2) 150.8 (147.8; 153.8) 145.1 (142.3; 147.9) 0.006 147.8 (145.0; 150.7) 147.8 (145.1; 150.5) 0.995 
PMI (mm4) 3860.1 (3709.5; 4010.6) 3577.4 (3434.9; 3719.8) 0.003
^^ 
3711.5 (3565.6; 3857.3) 3710.5 (3572.8; 
3848.1) 
0.950^^ 
PsC (mm) 43.4 (42.9; 43.8) 42.5 (42.1; 42.9) 0.005 42.9 (42.5; 43.3) 42.9 (42.5; 43.3) 0.988 
^Covariates appearing in the adjusted model are: Grade, length (cm) and weight (kg). 
^^logarithmic transformation 
a t; test, b analysis of covariance 
BMC= bone mineral content; vBMD= volumetric bone mineral density; CSA= cross; sectional area, PMI= polar moment of inertia, PsC=periosteal 




Table 3. Standardized coefficient, partial correlation and adjusted R2 of multiple linear 
regression on bone parameters at 12 months of age.  
Bone parameter and 
modifying variables 
 β (95% CI)  r  p  Adjusted R2 
     
BMC (mg/mm)     0.169* 
Weight  0.353 (0.275; 0.435)  0.317 <0.001  
Length  0.054 (-0.020; 0.123)  0.054  0.160  
Grade -0.117 (-0.145; -0.037) -0.127  0.001  
Sex -0.067 (-0.281; 0.015) -0.068  0.078  
     
vBMD (mg/cm3)     0.004** 
Weight  0.053 (-0.035; 0.141)  0.046  0.237   
Length  0.025 (-0.055; 0.102)  0.023  0.553  
Grade -0.063 (-0.108; 0.010) -0.063  0.104  
Sex -0.031 (-0.225; 0.100) -0.029  0.449  
     
CSA (mm2)     0.058*) 
Weight  0.235 (0.151; 0.322)  0.205 <0.001  
Length  0.027 (-0.050; 0.102)  0.026  0.506  
Grade -0.035 (-0.085; 0.030) -0.036  0.347  
Sex -0.011 (-0.179; 0.137) -0.010  0.793  
     
PMI (mm4)^     0.072* 
Weight  0.257 (0.174; 0.343)  0.225 <0.001  
Length  0.030 (-0.048; 0.104)  0.028  0.470  
Grade -0.026 (-0.078; 0.037) -0.027  0.482  
Sex -0.018 (-0.193; 0.120) -0.017  0.651  
     
PsC (mm)     0.065* 
Weight  0.246 (0.162; 0.333)  0.215 <0.001  
Length  0.028 (-0.049; 0.103)  0.026  0.492  
Grade -0.035 (-0.085; 0.030) -0.037  0.343  
Sex -0.014 (-0.186; 0.129) -0.014  0.723  
     
*= p<0.001 (significant), **=p>0.05 (insignificant) ^=logarithmic transformation 
Grade is a categorical variable (1-5) 
Sex is a dichotomous variable: boys value of 1, girls value of 2 
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Table 4. Standardized coefficient, partial correlation and adjusted R2 of multiple linear 
regression on bone parameters at 24 months of age.  
Bone parameter and 
modifying variables 
 β (95% CI)  r  p  Adjusted R2 
     
BMC (mg/mm)      0.334* 
Weight  0.426 (0.342; 0.521)  0.336 <0.001  
Length  0.176 (0.126; 0.376)  0.147 <0.001  
Grade -0.073 (-0.097; -0.010) -0.090  0.017  
Sex -0.040 (-0.206; 0.046) -0.047  0.212  
     
vBMD (mg/cm3)     0.002** 
Weight  0.083 (-0.026; 0.194)  0.057  0.133  
Length -0.014 (-0.173; 0.133) -0.010  0.794  
Grade -0.023 (-0.070; 0.037) -0.023  0.549  
Sex -0.028 (-0.211; 0.098) -0.027  0.472  
     
CSA (mm2)     0.121* 
Weight  0.233 (0.133; 0.339)  0.168 <0.001  
Length  0.148 (0.066; 0.353)  0.108  0.004  
Grade -0.018 (-0.063; 0.038) -0.019  0.618  
Sex -0.0002 (-0.145; 0.144) -0.0002  0.995  
     
PMI (mm4)^     0.136* 
Weight  0.239 (0.140; 0.344)  0.173 <0.001  
Length  0.163 (0.090; 0.374)  0.120  0.001  
Grade -0.012 (-0.059; 0.041) -0.013  0.725  
Sex -0.002 (-0.148; 0.139) -0.002  0.950  
     
PsC (mm)     0.126* 
Weight  0.232 (0.133; 0.338)  0.168 <0.001  
Length  0.156 (0.078; 0.364)  0.114  0.003  
Grade -0.022 (-0.066; 0.034) -0.024  0.532  
Sex -0.001 (-0.146; 0.143) -0.001  0.988  
     
*= p<0.001 (significant), **=p>0.05 (insignificant) ^=logarithmic transformation 
Grade is a categorical variable (1-5) 
Sex is a dichotomous variable: boys value of 1, girls value of 2 
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Figure 1. The pQCT scanner used in the study (Stratec XCT2000 L Research +) and a study subject 3 
positioning during pQCT imaging at age 24 months. 4 
 5 
  6 
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Figure 2. Images illustrating scan quality at 20% distal site of the left tibia in 24-month-old 7 
children. A) Grade 1: Cortex intact. B) Grade 2: Minimal movement artifacts visible. C) Grade 3: 8 
Some movement artifacts visible. D) Grade 4: Several movement artifacts visible. E) Grade 5: 9 
Cortex broken but bone shape definable. F) Grade 6: Unanalyzable scan, bone shape cannot be 10 
defined (excluded from analyses). 11 
 12 
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Figure 3. Participant flow chart. 14 
 15 
  16 
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Figure 4. Box plots showing distal tibial pQCT values for total bone measured at 12 and 24 months 17 
of age according to weight (kg)*. The middle line represents the median value, the top of the box is 18 
the 75th percentile and the bottom of the box is the 25th percentile. The whiskers represent the 5% 19 
and 95% percentiles. 20 
 21 
 22 
*Weight groups are: 7-8.99 kg, 9-10.99 kg, 11-12.99 kg, 13-14.99 kg, 15-16.99 kg   23 
27 
 
Figure 5. Box plots showing distal tibial pQCT values for total bone measured at 12 and 24 months 24 
of age according to length (cm). The middle line represents the median value, the top of the box is 25 
the 75th percentile and the bottom of the box is the 25th percentile. The whiskers represent the 5% 26 





SUPPLEMENTAL TABLE 1. Bone parameters for total bone at 12 and 24 months stratified by weight. 
Variable Group 1 (7.00-8.99 kg) Group 2 (9.00-10.99 kg) Group 3 (11.00-12.99 kg) Group 4 (13.00-14.99 kg) Group 5 (15.00-16.99 kg) p valuea, 
ANOVA 
N 169 496 483 202 36 N/A 
BMC (mg/mm) 30.2 (27.3 to 34.3) 36.2 (31.7 to 43.1) 51.8 (46.0 to 56.2) 57.2 (51.9 to 63.0) 64.9 (61.2 to 69.8) <0.001b 
vBMD (mg/cm3) 273.7 (227.6 to 331.8) 303.1 (251.4 to 355.9) 352.3 (306.9 to 414.5) 374.6 (328.9 to 426.6) 381.7 (323.3 to 442.8) <0.001c 
CSA (mm2) 108.0 (90.4 to 129.2) 121.1 (104.7 to 139.7) 140.5 (124.6 to 158.4) 151.2 (136.3 to 173.0) 170.2 (142.9 to 199.6) <0.001d 
PsC (mm) 36.8 (33.7 to 40.3) 39.0 (36.3 to 41.9) 42.0 (39.6 to 44.6) 43.6 (41.4 to 46.6) 46.2 (42.4 to 50.1) <0.001e 
PMI* (mm4) 1918.2 (1356.0 to 2735.8) 2388.7 (1808.3 to 3183.9) 3243.0 (2578.6 to 4104.2) 3757.9 (3061.4 to 4868.6) 4737.1 (3463.8 to 6508.7) <0.001f 
Data presented as median (IQR; 25% to 75%) 
Abbreviations: ANOVA, analysis of variance; BMC, bone mineral content; vBMD, volumetric bone mineral density; CSA, cross-sectional area; PsC, periosteal circumference; PMI, polar 
moment of inertia 
a. Subgroups compared with Tukey post hoc test with statistically significant difference at p < 0.010 
b. Tukey post hoc test insignificant between Group 4 vs Group 5 
c. Tukey post hoc test insignificant between Group 3 vs Group 4 and Group 5, Group 4 vs Group 5 
d. Tukey post hoc test insignificant between Group 4 vs Group 5 
e. Tukey post hoc test insignificant between Group 4 vs Group 5 
f. Tukey post hoc test insignificant between Group 4 vs Group 5 





SUPPLEMENTAL TABLE 2. Bone parameters for total bone at 12 and 24 months stratified by length.  
Variable Group 1 (70-75 cm) Group 2 (76-80 cm) Group 3 (81-85 cm) Group 4 (86-90 cm) Group 5 (91-95 cm) p valuea, 
ANOVA 
N 345 320 169 427 117 N/A 
BMC (mg/mm) 31.9 (28.5 to 36.7) 36.5 (32.4 to 41.3) 48.2 (44.1 to 53.0) 54.0 (50.0 to 58.8) 59.7 (54.6 to 65.6) <0.001 
vBMD (mg/cm3) 287.4 (237.6 to 338.0) 284.9 (244.3 to 341.6) 348.6 (309.7 to 417.2) 374.7 (326.0 to 424.7) 374.8 (320.7 to 433.1) <0.001b 
CSA (mm2) 110.9 (95.5 to 132.2) 123.8 (109.0 to 144.8) 134.6 (117.9 to 153.7) 144.8 (130.1 to 161.8) 160.0 (141.3 to 177.6) <0.001c 
PsC (mm) 37.3 (34.6 to 40.8) 39.4 (37.0 to 42.7) 41.1 (38.5 to 43.9) 42.7 (40.4 to 45.1) 44.8 (42.1 to 47.2) <0.001d 
PMI* (mm4) 2018.1 (1508.0 to 2869.7) 2501.7 (1950.6 to 3422.7) 2976.8 (2282.4 to 3874.7) 3430.9 (2778.0 to 4269.2) 4218.4 (3309.4 to 5148.5) <0.001 
Data presented as median (IQR; 25% to 75%) 
 
Abbreviations: ANOVA, analysis of variance; BMC, bone mineral content; vBMD, volumetric bone mineral density; CSA, cross-sectional area; PsC, periosteal circumference; PMI, polar 
moment of inertia 
a. Subgroups compared with Tukey post hoc test with statistically significant difference at p < 0.010 
b. Tukey post hoc test insignificant between Group 1 vs Group 2, Group 3 vs. Group 4 and Group 5, Group 4 vs. Group 5 
c. Tukey post hoc test insignificant between Group 2 vs Group 3 
d. Tukey post hoc test insignificant between Group 2 vs Group 3 




Supplemental figure 1. Box plots showing comparison of the unadjusted distal tibial pQCT values 
for total bone between 12 and 24 months of age according to sex. The middle line represents the 
median value, the top of the box the 75th percentile and the bottom of the box the 25th percentile. 





Supplemental figure 2. A scatterplot of total bone BMC vs length, vBMD vs length, BMC vs 
weight, and vBMD vs weight. Blue dots represents Grade 1-2 scans and red dots Grade 3-5 scans. 
Girls are marked with triangles and boys with circles. Blue solid line represents a trendline for girls 
with Grade 1-2 scans and a red solid line boys with Grade 1-2 scans. Blue dashed line represents a 
trendline for girls with Grade 3-5 scans and a red dashed line boys with Grade 3-5 scans.
 
 
